These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 39305136)

  • 1. Importance of non-cardiovascular comorbidities in atrial fibrillation and heart failure with preserved ejection fraction.
    Hamatani Y; Iguchi M; Kato T; Inuzuka Y; Tamaki Y; Ozasa N; Kawaji T; Esato M; Tsuji H; Wada H; Hasegawa K; Abe M; Kimura T; Ono K; Akao M;
    ESC Heart Fail; 2024 Sep; ():. PubMed ID: 39305136
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Utility of left ventricular ejection fraction in atrial fibrillation patients without pre-existing heart failure.
    Hamatani Y; Iguchi M; Minami K; Ishigami K; Esato M; Tsuji H; Wada H; Hasegawa K; Ogawa H; Abe M; Lip GYH; Akao M;
    ESC Heart Fail; 2023 Oct; 10(5):3091-3101. PubMed ID: 37604489
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of left atrial enlargement with heart failure events in non-valvular atrial fibrillation patients with preserved left ventricular ejection fraction.
    Hamatani Y; Iguchi M; Okamoto K; Nakanishi Y; Minami K; Ishigami K; Ikeda S; Doi K; Yoshizawa T; Ide Y; Fujino A; Ishii M; Masunaga N; Esato M; Tsuji H; Wada H; Hasegawa K; Abe M; Akao M
    Eur Heart J Open; 2024 Mar; 4(2):oeae015. PubMed ID: 38487366
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atrial Fibrillation can adversely impact Heart Failure with Preserved Ejection Fraction by its association with Heart Failure Progression and Mortality: A Post-Hoc Propensity Score-Matched Analysis of the TOPCAT Americas Trial.
    Saksena S; Slee A; Natale A; Lakkireddy DR; Shah D; Di Biase L; Lewalter T; Nagarakanti R; Santangeli P
    Europace; 2023 May; 25(5):. PubMed ID: 37078691
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential Prognostic Impact of Atrial Fibrillation in Hospitalized Heart Failure Patients With Preserved Ejection Fraction According to Coronary Artery Disease Status　- Report From the Japanese Nationwide Multicenter Registry.
    Temma T; Nagai T; Watanabe M; Kamada R; Takahashi Y; Hagiwara H; Koya T; Nakao M; Omote K; Kamiya K; Iwano H; Yamamoto K; Yoshikawa T; Saito Y; Anzai T
    Circ J; 2020 Feb; 84(3):397-403. PubMed ID: 32009066
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of heart rate changes during hospitalization on outcome in heart failure with preserved ejection fraction.
    Liu D; Cui X; Xu Y; Xu L; Xie Z; Yuan S; Wang P; Wang Y; Qian S; Gong H; Nordbeck P; Yang J; Zhou J; Ge J; Sun A
    ESC Heart Fail; 2024 Oct; 11(5):2901-2912. PubMed ID: 38514992
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dronedarone for the treatment of atrial fibrillation with concomitant heart failure with preserved and mildly reduced ejection fraction: a post-hoc analysis of the ATHENA trial.
    Vaduganathan M; Piccini JP; Camm AJ; Crijns HJGM; Anker SD; Butler J; Stewart J; Braceras R; Albuquerque APA; Wieloch M; Hohnloser SH
    Eur J Heart Fail; 2022 Jun; 24(6):1094-1101. PubMed ID: 35293087
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atrial fibrillation and risk of adverse outcomes in heart failure with reduced, mildly reduced, and preserved ejection fraction: A systematic review and meta-analysis.
    Kroshian G; Joseph J; Kinlay S; Peralta AO; Hoffmeister PS; Singh JP; Yuyun MF
    J Cardiovasc Electrophysiol; 2024 Apr; 35(4):715-726. PubMed ID: 38348517
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atrial Fibrillation in Heart Failure With Preserved, Mid-Range, and Reduced Ejection Fraction.
    Sartipy U; Dahlström U; Fu M; Lund LH
    JACC Heart Fail; 2017 Aug; 5(8):565-574. PubMed ID: 28711451
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CHA2DS2-VASc and ATRIA Scores and Clinical Outcomes in Patients with Heart Failure with Preserved Ejection Fraction.
    Zhu W; Wu Y; Zhou Y; Liang W; Xue R; Wu Z; Dong Y; Liu C
    Cardiovasc Drugs Ther; 2020 Dec; 34(6):763-772. PubMed ID: 32583288
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heart failure progression and mortality in atrial fibrillation patients with preserved or reduced left ventricular ejection fraction.
    Slee A; Saad M; Saksena S
    J Interv Card Electrophysiol; 2019 Sep; 55(3):325-331. PubMed ID: 30887281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictors for Stroke and Death in Non-Anticoagulated Asian Patients with Atrial Fibrillation: The Fushimi AF Registry.
    Hamatani Y; Yamashita Y; Esato M; Chun YH; Tsuji H; Wada H; Hasegawa K; Abe M; Lip GY; Akao M
    PLoS One; 2015; 10(11):e0142394. PubMed ID: 26540107
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcomes of patients with anemia and renal dysfunction in hospitalized heart failure with preserved ejection fraction (from the CN-HF registry).
    Jin X; Cao J; Zhou J; Wang Y; Han X; Song Y; Fan Y; Chen Z; Xu D; Yang X; Dong W; Li L; Chen L; Zhong Q; Fu M; Hu K; Zhou J; Ge J;
    Int J Cardiol Heart Vasc; 2019 Dec; 25():100415. PubMed ID: 31508483
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical impact of atrial fibrillation progression in patients with heart failure with preserved ejection fraction: A report from the CHART-2 Study.
    Ito T; Noda T; Nochioka K; Shiroto T; Yamamoto N; Sato H; Chiba T; Hasebe Y; Nakano M; Takahama H; Takahashi J; Miyata S; Shimokawa H; Yasuda S
    Europace; 2024 Aug; 26(9):. PubMed ID: 39150084
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heart failure in patients with atrial fibrillation in Europe: a report from the EURObservational Research Programme Pilot survey on Atrial Fibrillation.
    Lip GY; Laroche C; Popescu MI; Rasmussen LH; Vitali-Serdoz L; Dan GA; Kalarus Z; Crijns HJ; Oliveira MM; Tavazzi L; Maggioni AP; Boriani G
    Eur J Heart Fail; 2015 Jun; 17(6):570-82. PubMed ID: 25727992
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Usefulness of CHADS2, R2CHADS2, and CHA2DS2-VASc scores for predicting incident atrial fibrillation in heart failure with preserved ejection fraction patients.
    Wu Y; Xie Z; Liang W; Xue R; Wu Z; Wu D; He J; Zhu W; Liu C
    ESC Heart Fail; 2021 Apr; 8(2):1369-1377. PubMed ID: 33506643
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Age-Dependent Prognostic Impact of Paroxysmal Versus Sustained Atrial Fibrillation on the Incidence of Cardiac Death and Heart Failure Hospitalization (the Fushimi AF Registry).
    An Y; Ogawa H; Esato M; Ishii M; Iguchi M; Masunaga N; Aono Y; Ikeda S; Doi K; Tsuji H; Wada H; Hasegawa K; Abe M; Lip GYH; Akao M;
    Am J Cardiol; 2019 Nov; 124(9):1420-1429. PubMed ID: 31488250
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and effectiveness of left atrial appendage closure in atrial fibrillation patients with different types of heart failure.
    Liu L; Yan W; Xu X; Wan C; Liu F; Yao Q; Song L; Wang B; Song Z; Li H
    BMC Cardiovasc Disord; 2024 Aug; 24(1):430. PubMed ID: 39148039
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical characteristics and cardiovascular outcomes in patients with atrial fibrillation receiving rhythm-control therapy: the Fushimi AF Registry.
    An Y; Esato M; Ishii M; Iguchi M; Masunaga N; Tsuji H; Wada H; Hasegawa K; Ogawa H; Abe M; Lip GYH; Akao M
    Heart Vessels; 2018 Dec; 33(12):1534-1546. PubMed ID: 29797059
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence and Risk Factors of Stroke or Systemic Embolism in Patients With Atrial Fibrillation and Heart Failure　- The Fushimi AF Registry.
    Iguchi M; Tezuka Y; Ogawa H; Hamatani Y; Takagi D; An Y; Unoki T; Ishii M; Masunaga N; Esato M; Tsuji H; Wada H; Hasegawa K; Abe M; Lip GYH; Akao M
    Circ J; 2018 Apr; 82(5):1327-1335. PubMed ID: 29526914
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.